Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik Pels

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|July 25, 2003
Treatment options of AIDS-related lymphomaIngo G H Schmidt-Wolf, Jürgen K Rockstroh, Uwe Schlegel, et al.
Archives of Neurology|April 23, 2003
Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphomaKlaus Fliessbach, Horst Urbach, Christoph Helmstaedter, et al.
Critical Ultrasound Journal|February 28, 2014
Prehospital stroke diagnostics based on neurological examination and transcranial ultrasoundMoriz Herzberg, Sandra Boy, Thilo Hölscher, et al.
European Journal of Haematology|August 24, 2010
Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathologyRoland Schroers, Alexander Baraniskin, Christoph Heute, et al.
European Journal of Haematology|March 22, 2005
Imaging of central nervous system lymphomas with iodine-123 labeled rituximabMarkus Dietlein, Hendrik Pels, Holger Schulz, et al.
Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.
German Medical Science : GMS E-Journal|June 24, 2011
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysisKatrin Patrij, Marcel Reiser, Luise Wätzel, et al.
Neuro-Oncology|February 18, 2010
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphomaHendrik Pels, Annika Juergens, Isabell Schirgens, et al.
Neurology|September 29, 2020
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphomaSabine Seidel, Hendrik Pels, Sabine Schlömer, et al.
Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|July 25, 2003
Treatment options of AIDS-related lymphomaIngo G H Schmidt-Wolf, Jürgen K Rockstroh, Uwe Schlegel, et al.
Archives of Neurology|April 23, 2003
Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphomaKlaus Fliessbach, Horst Urbach, Christoph Helmstaedter, et al.
Critical Ultrasound Journal|February 28, 2014
Prehospital stroke diagnostics based on neurological examination and transcranial ultrasoundMoriz Herzberg, Sandra Boy, Thilo Hölscher, et al.
European Journal of Haematology|August 24, 2010
Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathologyRoland Schroers, Alexander Baraniskin, Christoph Heute, et al.
European Journal of Haematology|March 22, 2005
Imaging of central nervous system lymphomas with iodine-123 labeled rituximabMarkus Dietlein, Hendrik Pels, Holger Schulz, et al.
Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.
German Medical Science : GMS E-Journal|June 24, 2011
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysisKatrin Patrij, Marcel Reiser, Luise Wätzel, et al.
Neuro-Oncology|February 18, 2010
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphomaHendrik Pels, Annika Juergens, Isabell Schirgens, et al.
Neurology|September 29, 2020
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphomaSabine Seidel, Hendrik Pels, Sabine Schlömer, et al.
Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Pageof 3